Back
Cytokinetics Stock Price Chart

Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
27
CYTK
Cytokinetics
Last Price:
$39.47
Seasonality Move:
10.99%
7 Day Trial
ALL ACCESS PASS
$
7

Mode Mobile Could be Next in Line
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CYTK is experiencing buying pressure, which is a positive indicator for future bullish movement.
Cytokinetics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 38.17 | Buy |
20-day SMA: | 40.18 | Sell |
50-day SMA: | 43.1 | Sell |
200-day SMA: | 50.54 | Sell |
8-day EMA: | 38.64 | Buy |
20-day EMA: | 34.45 | Buy |
50-day EMA: | 22.62 | Buy |
200-day EMA: | 7.61 | Buy |
Cytokinetics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.16 | Buy |
Relative Strength Index (14 RSI): | 46.41 | Sell |
Chaikin Money Flow: | 979616 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (37.71 - 44.11) | Sell |
Bollinger Bands (100): | (41.9 - 50.06) | Sell |
Cytokinetics Technical Analysis
Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Cytokinetics Stock
Is Cytokinetics Stock a Buy?
-
Cytokinetics share price is 39.48 while CYTK 8-day simple moving average is 38.17, which is a Buy signal.
-
The stock price of CYTK is 39.48 while Cytokinetics 20-day SMA is 40.18, which makes it a Sell.
-
Cytokinetics 50-day simple moving average is 43.10 while CYTK share price is 39.48, making it a Sell technically.
-
CYTK stock price is 39.48 and Cytokinetics 200-day simple moving average is 50.54, creating a Sell signal.
CYTK Technical Analysis vs Fundamental Analysis
Sell
27
Cytokinetics (CYTK)
is a Sell
Is Cytokinetics a Buy or a Sell?
-
Cytokinetics stock is rated a SellThe current Cytokinetics [CYTK] share price is $39.48. The Score for CYTK is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
Cytokinetics Stock Info
Market Cap:
4.7B
Price in USD:
39.48
Share Volume:
1.1M
Cytokinetics 52-Week Range
52-Week High:
68.76
52-Week Low:
32.74
Sell
27
Cytokinetics (CYTK)
is a Sell
Cytokinetics Share Price Forecast
-
What is the Cytokinetics stock price today?The Cytokinetics stock price is 39.48 USD today.
-
Will CYTK stock go up or go down?Cytokinetics> share price is forecast to RISE/FALL based on technical indicators
-
Is Cytokinetics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cytokinetics is overvalued.
Is Cytokinetics Stock a Buy?
-
Cytokinetics share price is 39.48 while CYTK 8-day exponential moving average is 38.64, which is a Buy signal.
-
The stock price of CYTK is 39.48 while Cytokinetics 20-day EMA is 34.45, which makes it a Buy.
-
Cytokinetics 50-day exponential moving average is 22.62 while CYTK share price is 39.48, making it a Buy technically.
-
CYTK stock price is 39.48 and Cytokinetics 200-day simple moving average is 7.61, creating a Buy signal.
Fundamental Analysis of Cytokinetics
Is Cytokinetics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.24 per share, an increase next quarter of $0.27 per share, a decrease this year of $0.46 per share, and an increase next year of $0.70 per share.
Technical Analysis of Cytokinetics
Should I short Cytokinetics stock?
-
CYTK Moving Average Covergence Divergence (MACD) indicator is 6.16, suggesting Cytokinetics is a Buy
-
Cytokinetics Relative Strength Index (RSI) is 46.41, which suggest Cytokinetics is oversold
-
The Bollinger Bands (25) for Cytokinetics is (37.71 - 44.11), which suggest Cytokinetics is a Sell
-
The Bollinger Bands (100) for Cytokinetics is (41.9 - 50.06), which suggest Cytokinetics is a Sell
* Cytokinetics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.